Cixutumumab-associated pancolitis in a patient with prostate cancer.
Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
Mehmet Asim
MA
Bilen
Jeri
J
Kim
Huamin
H
Wang
Shi-Ming
SM
Tu
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003092:Colitis / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors* / Q000276:immunology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C557414:cixutumumab; D017526:Receptor, IGF Type 1